Artisan Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-117,345
| Closed | -$19.2M | – | 316 |
|
2022
Q1 | $19.2M | Sell |
117,345
-121,791
| -51% | -$19.9M | 0.03% | 285 |
|
2021
Q4 | $40.6M | Sell |
239,136
-3,648
| -2% | -$619K | 0.05% | 256 |
|
2021
Q3 | $45.8M | Buy |
242,784
+4,202
| +2% | +$793K | 0.06% | 246 |
|
2021
Q2 | $40.4M | Buy |
238,582
+10,394
| +5% | +$1.76M | 0.05% | 257 |
|
2021
Q1 | $32.2M | Buy |
228,188
+28,015
| +14% | +$3.96M | 0.04% | 272 |
|
2020
Q4 | $26M | Buy |
200,173
+36,481
| +22% | +$4.74M | 0.03% | 268 |
|
2020
Q3 | $23.8M | Buy |
163,692
+36,867
| +29% | +$5.37M | 0.03% | 260 |
|
2020
Q2 | $18.8M | Buy |
126,825
+20,599
| +19% | +$3.05M | 0.03% | 263 |
|
2020
Q1 | $11.6M | Buy |
+106,226
| New | +$11.6M | 0.02% | 257 |
|
2016
Q4 | – | Sell |
-221,733
| Closed | -$15M | – | 260 |
|
2016
Q3 | $15M | Sell |
221,733
-3,470
| -2% | -$235K | 0.03% | 231 |
|
2016
Q2 | $12.5M | Sell |
225,203
-8,456
| -4% | -$469K | 0.03% | 230 |
|
2016
Q1 | $14.7M | Sell |
233,659
-4,364
| -2% | -$274K | 0.03% | 235 |
|
2015
Q4 | $22.4M | Sell |
238,023
-6,881
| -3% | -$648K | 0.04% | 217 |
|
2015
Q3 | $19.7M | Sell |
244,904
-774,376
| -76% | -$62.2M | 0.04% | 221 |
|
2015
Q2 | $122M | Sell |
1,019,280
-65,280
| -6% | -$7.83M | 0.23% | 136 |
|
2015
Q1 | $113M | Buy |
1,084,560
+793,178
| +272% | +$82.8M | 0.2% | 142 |
|
2014
Q4 | $28.3M | Sell |
291,382
-256,474
| -47% | -$24.9M | 0.05% | 233 |
|
2014
Q3 | $42.8M | Sell |
547,856
-27,002
| -5% | -$2.11M | 0.08% | 201 |
|
2014
Q2 | $36.3M | Buy |
574,858
+55,975
| +11% | +$3.54M | 0.06% | 230 |
|
2014
Q1 | $34.8M | Buy |
518,883
+75,161
| +17% | +$5.05M | 0.06% | 235 |
|
2013
Q4 | $28.5M | Buy |
443,722
+20,899
| +5% | +$1.34M | 0.05% | 242 |
|
2013
Q3 | $27.1M | Buy |
+422,823
| New | +$27.1M | 0.05% | 250 |
|